Cargando…

Periostin is up-regulated in high grade and high stage prostate cancer

BACKGROUND: Expression of periostin is an indicator of epithelial-mesenchymal transition in cancer but a detailed analysis of periostin expression in prostate cancer has not been conducted so far. METHODS: Here, we evaluated periostin expression in prostate cancer cells and peritumoural stroma immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tischler, Verena, Fritzsche, Florian R, Wild, Peter J, Stephan, Carsten, Seifert, Hans-Helge, Riener, Marc-Oliver, Hermanns, Thomas, Mortezavi, Ashkan, Gerhardt, Josefine, Schraml, Peter, Jung, Klaus, Moch, Holger, Soltermann, Alex, Kristiansen, Glen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903527/ https://www.ncbi.nlm.nih.gov/pubmed/20534149 http://dx.doi.org/10.1186/1471-2407-10-273

Ejemplares similares

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
por: Ikenberg, Kristian, et al.
Publicado: (2010)

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2014)

GOLPH2 expression in renal cell cancer
por: Fritzsche, Florian Rudolf, et al.
Publicado: (2008)

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer
por: Tischler, Verena, et al.
Publicado: (2011)

MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer
por: von Boehmer, Lotta, et al.
Publicado: (2011)

Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy
por: Zeh, Nina, et al.
Publicado: (2013)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update
por: Morra, Laura, et al.
Publicado: (2011)

Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer
por: Kempkensteffen, Carsten, et al.
Publicado: (2009)

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients
por: Zhong, Qing, et al.
Publicado: (2017)

GOLPH2 expression may serve as diagnostic marker in seminomas
por: Fritzsche, Florian R, et al.
Publicado: (2010)

Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study
por: Velizheva, Nadezda P., et al.
Publicado: (2018)

Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer
por: Varga, Zsuzsanna, et al.
Publicado: (2013)

Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer
por: Varga, Zsuzsanna, et al.
Publicado: (2013)

Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment
por: Kuett, Laura, et al.
Publicado: (2022)

Homogeneous MGMT Immunoreactivity Correlates with an Unmethylated MGMT Promoter Status in Brain Metastases of Various Solid Tumors
por: Ingold, Barbara, et al.
Publicado: (2009)

Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers
por: Aimi, Fabio, et al.
Publicado: (2021)

Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma
por: Vrugt, Bart, et al.
Publicado: (2023)

Expression of periostin according to endometrial cancer grade
por: Herkiloglu, Dilsad, et al.
Publicado: (2022)

Differential Expression of Dickkopf 1 and Periostin in Mouse Strains with High and Low Bone Mass
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2022)

Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
por: Lakshminarayanan, Harini, et al.
Publicado: (2020)

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
por: Bonde, Anne-Katrine, et al.
Publicado: (2012)

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell
por: Kudo, Akira
Publicado: (2011)

Tumor Cell Plasticity and Angiogenesis in Human Melanomas
por: Mihic-Probst, Daniela, et al.
Publicado: (2012)

Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer
por: Pflueger, Dorothee, et al.
Publicado: (2015)

VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma
por: Razafinjatovo, Caroline Fanja, et al.
Publicado: (2016)

Periostin in cerebrovascular disease
por: Kawakita, Fumihiro, et al.
Publicado: (2019)

Periostin in Allergy and Inflammation
por: Sonnenberg-Riethmacher, Eva, et al.
Publicado: (2021)

Role of periostin in ECRS
por: Yu, Lei, et al.
Publicado: (2020)

Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer
por: Noske, Aurelia, et al.
Publicado: (2016)

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013)

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine
por: Bolck, Hella A., et al.
Publicado: (2019)

The role of periostin in kidney diseases
por: Turczyn, Agnieszka, et al.
Publicado: (2021)

Periostin: biology and function in cancer
por: Dorafshan, Shima, et al.
Publicado: (2022)

Periostin in Osteoporosis and Cardiovascular Disease
por: Pickering, Marie-Eva, et al.
Publicado: (2023)

High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma
por: Hu, Fei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ra0ekvm3ounuhocc9c590p2ltl